Reducing Blood Loss During Cesarean Myomectomy With Tranexamic Acid

• Status: Completed
• Trial end date: 2020-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study was a double-blinded randomized controlled study conducted at Aswan University, Egypt from January 2018 to January 2020. Study inclusion criteria were women who attended the outpatient obstetric clinic, seeking antenatal care diagnosed with leiomyomas with pregnancy and with myoma staging from (3 to 6) according to FIGO staging. scheduled to undergo cesarean myomectomy (11) Exclusion criteria were: 1-Patients undergone vaginal delivery.2-Patients with a history of thromboembolic disease. 3-Cervical and broad ligament myoma. 4-Myoma FIGO staging

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• women who attended the outpatient gynecology clinic, seeking treatment for symptomatic leiomyomas and scheduled to undergo abdominal myomectomy with myoma staging from (3 to 6) according to FIGO staging

Exclusion Criteria:

1. Patients undergone vaginal or laparoscopic myomectomy.

2. Patients received preoperative embolization or gonadotrophin releasing hormone analog.

3. Cervical and broad ligament myoma.

4. Patients with cardiac, hepatic, renal or thromboembolic disease

5. patients had an allergy to tranexamic acid).